All Bjork-Shiley Convexo-Concave Heart Valve Implantees: Please Read, Important Notice

Filed in archive Diagnostics on September 14, 2006

All bjork-Shiley Convexo-Concave Heart Valves (BSCC) were removed from the market by the manufacturer because if a risk of strut fracture that may result in death or serious injury.

Worldwide, approximately 86,000 of these heart valves were implanted in patients. Under a class action settlement agreement in the Bowling, et al. v. Pfizer Inc., et al. heart valve litigation, financial benefits are still available to certain patients implanted with the BSCC heart valve.

The risk of fracture depends on the patient's age, gender, valve size, valve implant position, and certain valve manufacturing characteristics; therefore it is really important that patients contact a cardiologist to discuss whether they are at an increased risk of fracture or possibly a candidate for a valve replacement.

If you have a Bjork-Shiley Convexo-Concave Heart Valve, you are urged
to register your name and address with the court-appointed Bowling
Settlement Claims Administrator to find information about your class action settlement benefits.

Registering is free and without obligation:

Wayne Smith, Bowling Claims Administrator
525 Vine Street, Suite 2300
Cincinnati, Ohio 45202 U.S.A.

Telephone: 513-421-4415 (English only)
Toll Free: 800-977-0779 (U.S. or Canada - English only)
Fax: 513-421-7696

E-mail: bowlingpfizer@fuse.net

Website: http://www.bowling-pfizer.com

Source: PR Newswire

[Photo Credit: WebMD]